The chemical class known as WDR36 inhibitors encompasses a variety of compounds designed to modulate the activity of the WDR36 protein. These inhibitors are tailored to target the specific functions and pathways associated with WDR36, a protein characterized by WD repeat domains known for their role in facilitating protein-protein interactions. The primary mechanism through which these inhibitors operate is by disrupting the interactions between WDR36 and other proteins, thereby impeding the formation of protein complexes essential for various cellular processes. This approach is crucial because it directly targets the scaffolding function of WDR36, which is central to its role in organizing proteins into complexes necessary for cellular signaling, cell cycle regulation, vesicular trafficking, and possibly gene expression regulation.
In addition to targeting protein-protein interactions, these inhibitors also focus on modulating the signaling pathways in which WDR36 is likely to be involved. By influencing these pathways, the inhibitors can indirectly affect the function of WDR36. For instance, when WDR36 plays a role in signal transduction, the inhibitors can alter the activity of specific signaling molecules or enzymes that interact with WDR36, thereby modulating the signaling cascades and affecting processes like cell growth and differentiation. Similarly, wehn WDR36 is involved in regulating the cell cycle, inhibitors that affect cell cycle progression can indirectly impact its function. Furthermore, in scenarios where WDR36 is implicated in gene expression regulation, inhibitors that influence transcription factors or the transcription machinery can modify WDR36's role in these processes. This aspect of the inhibitors is particularly relevant as it allows for the modulation of WDR36's function in a broader context, encompassing its various roles in cellular physiology. Overall, WDR36 inhibitors represent a diverse and intricate class of compounds with the influence of multiple aspects of WDR36's function within the cell. By targeting both the protein-protein interaction capabilities and the involvement of WDR36 in critical cellular pathways, these inhibitors provide a comprehensive approach to modulating the activity of WDR36. The development and study of WDR36 inhibitors are significant as they offer insights into the functions of WD repeat-containing proteins and the complex mechanisms of cellular regulation. Understanding how these compounds can modulate WDR36's activity enhances our knowledge of cellular processes and the strategies to influence them.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine could inhibit WDR36 by disrupting cellular signaling pathways, potentially affecting WDR36’s role in signal transduction. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide might inhibit WDR36 by reducing the protein synthesis required for WDR36's protein complex assembly functions. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole could inhibit WDR36 by disrupting microtubule dynamics, thereby affecting cell cycle regulation and vesicular trafficking processes involving WDR36. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel could inhibit WDR36 by stabilizing microtubules, influencing WDR36's role in cell cycle progression and trafficking. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, might inhibit WDR36 by affecting the MAPK/ERK signaling pathway in which WDR36 may be involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, might inhibit WDR36 by impacting signaling pathways relevant to WDR36’s function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could inhibit WDR36 by affecting gene expression regulation, potentially influencing WDR36’s interactions with transcription machinery. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil could inhibit WDR36 by interfering with DNA synthesis and repair, impacting WDR36's role in cell cycle regulation or DNA repair. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a proteasome inhibitor, could inhibit WDR36 by preventing the degradation of ubiquitinated proteins, affecting processes where WDR36 is involved. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat could inhibit WDR36 by altering chromatin structure and gene expression, which may be relevant to WDR36’s regulatory functions. | ||||||